Fairmount Funds Management LLC

Spyre Therapeutics, Inc. ยท Director

Fairmount Funds Management LLC is listed in public filings as director. This Fairmount Funds Management LLC insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Spyre Therapeutics, Inc. (SYRE), Viridian Therapeutics, Inc. (VRDN), Cogent Biosciences, Inc. (COGT), Zenas BioPharma, Inc. (ZBIO), and Damora Therapeutics, Inc. (DMRA). Investors use Fairmount Funds Management LLC's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Spyre Therapeutics, Inc.SYRE$582k8k sharesGrant / ExerciseMay 27, 2026$582.0K8k shares$72.51--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Viridian Therapeutics, Inc.VRDN$87M5.1M sharesBuyMay 11, 2026$20.0M1.2M shares$17.00--
Cogent Biosciences, Inc.COGT$191M5.5M sharesSellMar 31, 2026$242.6M7M shares$34.66--
Zenas BioPharma, Inc.ZBIO$47M2.4M sharesBuyMar 31, 2026$3.0M150k shares$20.00--
Cogent Biosciences, Inc.COGT--39.4k sharesGrant / ExerciseMar 31, 2026Disclosure amount unavailable28k shares----
Cogent Biosciences, Inc.COGT--12.5M sharesGrant / ExerciseMar 31, 2026Disclosure amount unavailable7M shares----
Damora Therapeutics, Inc.DMRA$860k37.3k sharesGrant / ExerciseMar 23, 2026$860.1K37.3k shares$23.05--
Galecto, Inc.GLTO--574 sharesGrant / ExerciseFeb 9, 2026Disclosure amount unavailable2.9k shares----
Galecto, Inc.GLTO--1.1k sharesGrant / ExerciseFeb 9, 2026Disclosure amount unavailable5.8k shares----
Galecto, Inc.GLTO--2.9M sharesGrant / ExerciseFeb 9, 2026Disclosure amount unavailable2.9M shares----
Galecto, Inc.GLTO--5.8M sharesGrant / ExerciseFeb 9, 2026Disclosure amount unavailable5.8M shares----
Apogee Therapeutics, Inc.APGE$23M298.6k sharesSellJan 22, 2026$133.5M1.8M shares$76.30--
Cogent Biosciences, Inc.COGT$200M5.5M sharesSellJan 22, 2026$127.4M3.5M shares$36.40--
Viridian Therapeutics, Inc.VRDN$86M3.9M sharesBuyOct 23, 2025$10.0M454.5k shares$22.00--
Zenas BioPharma, Inc.ZBIO$42M2.2M sharesBuyOct 7, 2025$6.0M316.2k shares$19.00--
Oruka Therapeutics, Inc.ORKA$17M1.1M sharesGrant / ExerciseSep 17, 2025$5.0M333.3k shares$15.00--
Cogent Biosciences, Inc.COGT$81M9M sharesBuyJul 10, 2025$25.0M2.8M shares$9.00--
Apogee Therapeutics, Inc.APGE$602k14.5k sharesGrant / ExerciseJun 17, 2025$602.4K14.5k shares$41.66--
Zenas BioPharma, Inc.ZBIO$221k18.5k sharesGrant / ExerciseJun 10, 2025$220.9K18.5k shares$11.94--
Viridian Therapeutics, Inc.VRDN$012.5k sharesGrant / ExerciseJun 10, 2025$153.9K12.5k shares$12.31--
Viridian Therapeutics, Inc.VRDN$01.6k sharesGrant / ExerciseJun 9, 2025$12.5K1.6k shares$7.80--
Oruka Therapeutics, Inc.ORKA$206k17.5k sharesGrant / ExerciseJun 2, 2025$206.0K17.5k shares$11.77--
Spyre Therapeutics, Inc.SYRE$389k25k sharesGrant / ExerciseMay 29, 2025$388.8K25k shares$15.55--
Oruka Therapeutics, Inc.ORKA$799798.6k sharesGrant / ExerciseNov 19, 2024$160160k shares$0.001--
Oruka Therapeutics, Inc.ORKA--160 sharesGrant / ExerciseNov 19, 2024Disclosure amount unavailable160 shares----
Dianthus Therapeutics, Inc.DNTH--62.1k sharesOtherSep 27, 2024Disclosure amount unavailable62.1k shares----
Viridian Therapeutics, Inc.VRDN$65M3.4M sharesBuySep 13, 2024$30.0M1.6M shares$18.75--
Oruka Therapeutics, Inc.ORKA$15M638.6k sharesGrant / ExerciseSep 11, 2024$6.3M275k shares$23.00--
Oruka Therapeutics, Inc.ORKA--160 sharesGrant / ExerciseSep 11, 2024Disclosure amount unavailable160 shares----
Cogent Biosciences, Inc.COGT$6.2k6.2M sharesGrant / ExerciseJun 10, 2024$1.5K1.5M shares$0.001--
Cogent Biosciences, Inc.COGT--1.5k sharesGrant / ExerciseJun 10, 2024Disclosure amount unavailable1.5k shares----